Cargando…
Trial evaluating overall survival in epithelial ovarian cancer (eoc) patients in second remission with an autologous dendritic cell therapy targeting mucin 1
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4288731/ http://dx.doi.org/10.1186/2051-1426-2-S3-P72 |
| _version_ | 1782352015614017536 |
|---|---|
| author | Gargosky, Sharron Team, Canvas Clinical |
| author_facet | Gargosky, Sharron Team, Canvas Clinical |
| author_sort | Gargosky, Sharron |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4288731 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2014 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-42887312015-01-15 Trial evaluating overall survival in epithelial ovarian cancer (eoc) patients in second remission with an autologous dendritic cell therapy targeting mucin 1 Gargosky, Sharron Team, Canvas Clinical J Immunother Cancer Poster Presentation BioMed Central 2014-11-06 /pmc/articles/PMC4288731/ http://dx.doi.org/10.1186/2051-1426-2-S3-P72 Text en Copyright © 2014 Gargosky et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
| spellingShingle | Poster Presentation Gargosky, Sharron Team, Canvas Clinical Trial evaluating overall survival in epithelial ovarian cancer (eoc) patients in second remission with an autologous dendritic cell therapy targeting mucin 1 |
| title | Trial evaluating overall survival in epithelial ovarian cancer (eoc) patients in second remission with an autologous dendritic cell therapy targeting mucin 1 |
| title_full | Trial evaluating overall survival in epithelial ovarian cancer (eoc) patients in second remission with an autologous dendritic cell therapy targeting mucin 1 |
| title_fullStr | Trial evaluating overall survival in epithelial ovarian cancer (eoc) patients in second remission with an autologous dendritic cell therapy targeting mucin 1 |
| title_full_unstemmed | Trial evaluating overall survival in epithelial ovarian cancer (eoc) patients in second remission with an autologous dendritic cell therapy targeting mucin 1 |
| title_short | Trial evaluating overall survival in epithelial ovarian cancer (eoc) patients in second remission with an autologous dendritic cell therapy targeting mucin 1 |
| title_sort | trial evaluating overall survival in epithelial ovarian cancer (eoc) patients in second remission with an autologous dendritic cell therapy targeting mucin 1 |
| topic | Poster Presentation |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4288731/ http://dx.doi.org/10.1186/2051-1426-2-S3-P72 |
| work_keys_str_mv | AT gargoskysharron trialevaluatingoverallsurvivalinepithelialovariancancereocpatientsinsecondremissionwithanautologousdendriticcelltherapytargetingmucin1 AT teamcanvasclinical trialevaluatingoverallsurvivalinepithelialovariancancereocpatientsinsecondremissionwithanautologousdendriticcelltherapytargetingmucin1 |